OFI Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$596K Sell
36,339
-1,114
-3% -$19K 0.04% 587
2015
Q2
$663K Buy
37,453
+993
+3% +$17.7K 0.04% 589
2015
Q1
$647K Sell
36,460
-9,327
-20% -$147K 0.04% 595
2014
Q4
$607K Sell
45,787
-345
-0.7% -$4.41K 0.04% 588
2014
Q3
$545K Buy
46,132
+2,973
+7% +$37.4K 0.04% 579
2014
Q2
$551K Buy
43,159
+4,242
+11% +$55.2K 0.04% 577
2014
Q1
$526K Sell
38,917
-3,071
-7% -$40.3K 0.04% 553
2013
Q4
$505K Buy
41,988
+3,806
+10% +$45K 0.04% 540
2013
Q3
$448K Sell
38,182
-7,953
-17% -$86K 0.04% 499
2013
Q2
$428K Buy
+46,135
New +$391K 0.04% 462

Other funds holding BSX

OFI Advisors's BSX Position: Q3 2015 in Review

OFI Advisors reduced its Boston Scientific (BSX) stake by 3% in Q3 2015, selling an estimated $19K and leaving 36,339 shares worth $596K. The position accounts for 0.04% of the portfolio, ranked #587.

OFI Advisors first reported a position in BSX in Q2 2013 and has held it in 10 quarters since. The position peaked at $663K in Q2 2015. 480 funds tracked by Wall St. Rank hold BSX as of Q3 2015.

  • OFI Advisors held 36,339 shares of Boston Scientific worth $596K as of Q3 2015.
  • OFI Advisors sold 1,114 Boston Scientific shares in Q3 2015, an estimated $19K.
  • Boston Scientific made up 0.04% of OFI Advisors's portfolio in Q3 2015, its #587 holding.
  • OFI Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Boston Scientific position peaked at $663K in Q2 2015.
  • 480 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.